Drug Development
Influenza protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors
Published in Gene Therapy Weekly, June 1st, 2006
According to recent research from the United States, "Lentivirus-based gene transfer has the potential to efficiently deliver DNA-based therapies into non-dividing epithelial cells of the airway for the treatment of lung diseases such as cystic fibrosis. However, significant barriers both to lung-specific gene transfer and to production of lentivirus vectors must be overcome before these vectors can be routinely used for applications to the lung."
"In this study, we investigated whether the ability to produce lentiviral vectors pseudotyped with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-06-01)
More Articles from Gene Therapy Weekly
- Adverse Drug Reaction
Prolonged beta-interferon stimulation causes DNA damage signaling and p53-dependent senescence - Developmental Biology
Lung morphogenesis is influenced by Iroquois genes during development - Developmental Biology
Osteoblastic differentiation markers altered by connexin43 modulation - Hepatitis B Virus
HBV gene expression and replication are inhibited by stable RNA interference - Neuroscience
Developing aneural myotubes display myogenin-dependent nAChR clustering - Allergy & Immunology
Deacetylation regulates innate antiviral response and beta interferon gene expression - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
